In two similar-worded orders, the Securities and Exchange Board of India (Sebi) has disposed of the adjudication proceedings against -- Keyur Jagdishbhai Kakrecha and Mohammad Sadik Abdulkader Malek -- saying allegation against them "is not established".
Sebi had alleged both the individuals of artificially inflating the price of the UTI Sunder ETF (Exchange Traded Fund) and also giving a false and misleading appearance of trading in the fund during the period August 1 to November 4, 2011.
However, in its orders today the regulator observed that Kakrecha and Malek "had executed only one self trade in the UTI Sunder ETF (and that too for only one unit (minimum trading lot)".
It further observed that self trade value of Kakrecha and Malek was Rs 2,650 and Rs 1,140, respectively, which "will not amount to artificially inflating the price of UTI Sunder ETF and will also not give a false and misleading appearance of trading in UTI Sunder ETF as alleged in the Show Cause Notice".
Sebi had observed that UTI Sunder ETF opened at the BSE at Rs 660 on August 3, 2011 and closed at Rs 2,054 on November 4, 2011.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)